Activation of natural killer (NK) cells and methods of use
OwnerSina Bavari, Kelly Warfieldinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to filovirus VLPs and their use in activating innate immunity, specifically natural killer cells, and in enhancing an immune response to an antigen in an animal.
Claims24
A method for activating an immune system of an animal which comprises administering filovirus virus like particles, VLPs, in an amount effective to activate an immune response in the animal.
A composition for activating an immune system comprising filovirus VLPs.
A composition for enhancing an immune response to an antigen in an animal comprising filovirus VLPs and said antigen.
The composition of claim 13 further comprising other filovirus proteins chosen from the group consisting of NP, VP24, VP30, and VP35.
Dependencies are inferred from the claim text.